Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
579 JPY | +0.87% | +3.39% | -50.60% |
31.05. | Gewinn von JCR Pharmaceuticals steigt im Gesamtjahr um 46 | MT |
27.05. | JCR PHARMACEUTICALS CO., LTD. : Jefferies & Co. bekräftigt seine neutrale Bewertung | ZM |
ETFs investiert in JCR Pharmaceuticals Co., Ltd.
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
1,67% | 22 M€ | +2.66% | - | |
0,30% | 19 M€ | +11.00% | ||
0,07% | 57 M€ | +20.52% | ||
0,05% | 4 M€ | +19.76% | ||
0,04% | 70 M€ | +18.13% | ||
0,03% | 17 M€ | +14.54% | - | |
0,02% | 4 929 M€ | +19.60% | ||
0,02% | 9 760 M€ | +19.92% | ||
0,02% | 20 360 M€ | +18.34% | - | |
0,02% | 140 441 M€ | +19.42% | ||
0,02% | 63 295 M€ | +19.48% | - | |
0,01% | 746 M€ | -.--% | - | |
0,01% | 7 M€ | +5.36% | - | |
0,01% | 32 M€ | +0.28% | - | |
0,00% | 10 M€ | -3.35% | - | |
0,00% | 32 M€ | +6.87% | - | |
0,00% | 34 M€ | +7.50% | - | |
0,00% | 391 M€ | +7.63% | - | |
0,00% | 39 M€ | +5.00% | - | |
0,00% | 306 M€ | +5.07% | - | |
0,00% | 34 M€ | +3.86% | - |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-50.60% | 456 Mio. | |
+40.73% | 739 Mrd. | |
+32.83% | 598 Mrd. | |
-6.30% | 353 Mrd. | |
+15.15% | 318 Mrd. | |
+4.05% | 285 Mrd. | |
+15.00% | 240 Mrd. | |
+9.78% | 210 Mrd. | |
-5.52% | 206 Mrd. | |
+6.17% | 164 Mrd. |
- Börse
- Aktien
- 889627 Aktie
- ETFs JCR Pharmaceuticals Co., Ltd.